Company / PP&E per Share
Matinas BioPharma Holdings, Inc. PP&E per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.11
FY2024
5-year range
$0.01 / $0.11
FY2020-FY2024
Trend
+1116.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share changed +1117% YoY in FY2024, a notable deviation from the 9-year average annual change of +146%.
Based on SEC 10-K filings.
0.11 in FY2024 with a 5-year CAGR of +47.5%.
Improved from $0.01 to $0.11 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +141.1%
- 5-Year CAGR
- +47.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, pp&e per share increased 1116.8% year-over-year.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.11 | +1116.8% |
| FY2023 | $0.01 | -8.5% |
| FY2022 | $0.01 | +25.8% |
| FY2021 | $0.01 | -17.7% |
| FY2020 | $0.01 | -39.5% |
| FY2019 | $0.02 | -29.4% |
| FY2018 | $0.02 | -18.9% |
| FY2017 | $0.03 | +333.4% |
| FY2016 | $0.01 | -46.8% |
| FY2015 | $0.01 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026